Brief: Nestmedic Adopts 2018-2023 Strategy

Nestmedic SA

08/05/2018 09:08

May 8 (Reuters) - NESTMEDIC SA  NSTP.WA :
    * ADOPTS 2018-2023 STRATEGY
    * AS PART OF THE NEW STRATEGY, THE GROUP PLANS GRADUALLY
ENTER
SOME FOREIGN MARKETS
    * IT HAS IDENTIFIED AROUND 20 MARKETS WHERE IT PLANS TO
DEVELOP
RELATIONS AND COOPERATION WITH LOCAL PARTNERS OVER 2018-2023 TO
START DISTRIBUTION AND SALES OF PREGNABIT 
    * ITS RESEARCH AND DEVELOPMENT TEAM WILL CONTINUE R&D
ACTIVITY TO
IMPLEMENT PREGNABIT 2.0 SYSTEM, WHICH IS PLANNED TO BE RELEASED
IN 2020
    * AS PART OF THE STRATEGY, THE MANAGEMENT AIMS TO REACH
2018-2023
AGGREGATED REVENUE BETWEEN 149-307 MILLION ZLOTYS
    * EBITDA MARGIN AT 50-60 PERCENT AT THE END OF 2023
    * SHARE OF EXPORT IN THE COMPANY'S REVENUE AT OVER 90
PERCENT 

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nEMbcMR0va
    
 Further company coverage:  NSTP.WA  
   


 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))